Dr. Paul von Bünau
Managing Director
- paul.buenau@idalab.de
- Office: +49 30 84 424 500
- Mobile: +49 173 24 16 000
Dr. Paul von Bünau is the Managing Director of idalab. A mathematician by training, he has spent more than a decade supporting numerous biotech, pharma and medtech companies on AI strategy and technology. He lives in Berlin with his partner Louise East and two kids.
Paul is a frequent speaker on AI in healthcare, serves as a lecturer at the Europa-Universität Viadrina and loves to mentor nascent startups on what may, or may not, be possible.
Education
- Ph.D. in Machine Learning with Computational Neuroscience (TU Berlin)
- M.Sc. in Pure Mathematics (University of St Andrews, Scotland)
- B.Sc. in Computer Science with Mathematics and Physics (University Potsdam)
Focus
Pharma Biotech
Market Access and Pricing: Bespoke AI for Expert Teams
Health technology market access has outgrown its tools. MA&P teams need bespoke AI fitted to their strategy, evidence base and workflows. We support from strategy to implementation.
Investors
Healthcare Buy & Build: AI Strategy and Implementation
Leveraging data, workflows and patient/HCP touchpoints with AI can be significant value driver. As one team, we support from transaction to value creation plan to execution.
Articles
Buy, Build or Wait: AI for Market Access Teams
AI buy-vs-build is different for in MA&P. A walk through the trade-offs, and what they imply for the use cases everyone's talking about.
PICO Prediction: How good is off-the-shelf AI?
Using the first Oncology JCA (tovorafenib) as a test case, we asked Claude and Gemini for their predictions. Will they hold up?
The State of AI at World EPA Congress 2026
The debate is settled: AI is not a hype. Concrete use cases, impact, best practices: our notes from the World EPA Congress 2026.